Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment
- PMID:26512171
- PMCID: PMC4622891
- DOI: 10.5021/ad.2015.27.5.563
Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment
Abstract
Background: Since the treatment guidelines for atopic dermatitis (AD) were released by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been several advances in AD management.
Objective: We aimed to establish updated evidence- and experience-based treatment guidelines for Korean AD.
Methods: We collected a database of references from relevant systematic AD reviews and guidelines regarding general AD management such as bathing and skin care, avoidance of exacerbating factors, education and psychosocial support, and the use of moisturizers and topical anti-inflammatory and antipruritic drugs. Evidence for each statement was graded and the strength of the recommendation for each statement classified. Thirty-nine KADA council members participated in three rounds of voting to establish an expert consensus of recommendations.
Results: Basic AD treatment includes proper bathing and skin care, avoidance of exacerbating factors, proper education and psychosocial support, and use of moisturizers. The regular use of moisturizer has a steroid-sparing effect and reduces relapse episodes. The short- and long-term use of topical corticosteroids and calcineurin inhibitors improves AD symptoms and should be encouraged to use in an active and proactive treatment. Wet-wrap therapy can be used for rapid recovery of acute exacerbation. Topical antipruritic drugs cannot be recommended for the treatment of AD.
Conclusion: This report provides up-to-date evidence- and experience-based treatment guidelines for AD regarding general management and topical treatment. In addition, the average agreement scores obtained by a panel of experts based on the Korean healthcare system and patient adherence are presented.
Keywords: Administration; Guideline; Therapeutics; topical.
Conflict of interest statement
Figures

Similar articles
- Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment.Kim JE, Kim HJ, Lew BL, Lee KH, Hong SP, Jang YH, Park KY, Seo SJ, Bae JM, Choi EH, Suhr KB, Lee SC, Ko HC, Park YL, Son SW, Seo YJ, Lee YW, Cho SH, Park CW, Roh JY.Kim JE, et al.Ann Dermatol. 2015 Oct;27(5):578-92. doi: 10.5021/ad.2015.27.5.578. Epub 2015 Oct 2.Ann Dermatol. 2015.PMID:26512172Free PMC article.
- Consensus Update for Systemic Treatment of Atopic Dermatitis.Lee JH, Kim JE, Park GH, Bae JM, Byun JY, Shin MK, Han TY, Hong SP, Jang YH, Kim HO, Na CH, Lew BL, Ahn J, Park CO, Seo YJ, Lee YW, Son SW, Choi EH, Park YL, Roh JY.Lee JH, et al.Ann Dermatol. 2021 Dec;33(6):497-514. doi: 10.5021/ad.2021.33.6.497. Epub 2021 Nov 4.Ann Dermatol. 2021.PMID:34858001Free PMC article.
- A comparison of international management guidelines for atopic dermatitis.LePoidevin LM, Lee DE, Shi VY.LePoidevin LM, et al.Pediatr Dermatol. 2019 Jan;36(1):36-65. doi: 10.1111/pde.13678. Epub 2018 Oct 10.Pediatr Dermatol. 2019.PMID:30303557Review.
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, Gieler U, Girolomoni G, Lau S, Muraro A, Czarnecka-Operacz M, Schäfer T, Schmid-Grendelmeier P, Simon D, Szalai Z, Szepietowski JC, Taïeb A, Torrelo A, Werfel T, Ring J; European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS).Wollenberg A, et al.J Eur Acad Dermatol Venereol. 2018 May;32(5):657-682. doi: 10.1111/jdv.14891.J Eur Acad Dermatol Venereol. 2018.PMID:29676534
- Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.Hussain Z, Sahudin S, Thu HE, Shuid AN, Bukhari SN, Kumolosasi E.Hussain Z, et al.Crit Rev Ther Drug Carrier Syst. 2016;33(3):213-263. doi: 10.1615/CritRevTherDrugCarrierSyst.2016015219.Crit Rev Ther Drug Carrier Syst. 2016.PMID:27910751Review.
Cited by
- Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia-Pacific Region: A Cross-sectional Survey.Chu CY, Chan Y, Wananukul S, Cheng H, Chandran NS, Bhat R, Son SW, Liao HF, Gardiner S, Ng QQ, Yeo SH, Chen SB, Kataoka Y.Chu CY, et al.Dermatol Ther (Heidelb). 2024 Sep;14(9):2479-2493. doi: 10.1007/s13555-024-01244-7. Epub 2024 Aug 5.Dermatol Ther (Heidelb). 2024.PMID:39103673Free PMC article.
- A clinician's reference guide for the management of atopic dermatitis in Asians.Chow S, Seow CS, Dizon MV, Godse K, Foong H, Chan V, Khang TH, Xiang L, Hidayat S, Listiawan MY, Triwahyudi D, Gondokaryono SP, Sutedja E, Diana IA, Suwarsa O, Dharmadji HP, Siswati AS, Danarti R, Soebaryo R, Budianti WK; Asian Academy of Dermatology & Venereology.Chow S, et al.Asia Pac Allergy. 2018 Oct 29;8(4):e41. doi: 10.5415/apallergy.2018.8.e41. eCollection 2018 Oct.Asia Pac Allergy. 2018.PMID:30402408Free PMC article.
- Current Management of Moderate-to-Severe Atopic Dermatitis: A Survey of Allergists, Pediatric Allergists and Dermatologists in Korea.Yum HY, Kim HH, Kim HJ, Kim WK, Lee SY, Li K, Lee DH; KAAACI Work Group on Severe/Recalcitrant Atopic Dermatitis.Yum HY, et al.Allergy Asthma Immunol Res. 2018 May;10(3):253-259. doi: 10.4168/aair.2018.10.3.253.Allergy Asthma Immunol Res. 2018.PMID:29676072Free PMC article.
- Capacitance and transepidermal water loss after soaking in water for different durations: A pilot study.Nitiyarom R, Withitanawanit T, Wisuthsarewong W.Nitiyarom R, et al.Skin Res Technol. 2022 Jan;28(1):98-103. doi: 10.1111/srt.13097. Epub 2021 Aug 29.Skin Res Technol. 2022.PMID:34455630Free PMC article.Clinical Trial.
- Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Korea.Woo YR, Kim HS.Woo YR, et al.J Clin Med. 2023 May 29;12(11):3744. doi: 10.3390/jcm12113744.J Clin Med. 2023.PMID:37297937Free PMC article.Review.
References
- Elias PM, Eichenfield LF, Fowler JF, Jr, Horowitz P, McLeod RP. Update on the structure and function of the skin barrier: atopic dermatitis as an exemplar of clinical implications. Semin Cutan Med Surg. 2013;32(2 Suppl 2):S21–S24. - PubMed
- Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26:1045–1060. - PubMed
- Rubel D, Thirumoorthy T, Soebaryo RW, Weng SC, Gabriel TM, Villafuerte LL, et al. Consensus guidelines for the management of atopic dermatitis: an Asia-Pacific perspective. J Dermatol. 2013;40:160–171. - PubMed
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources